Meeting
2013 ASCO Annual Meeting
Phase II study of de-intensification of radiation and chemotherapy for low-risk HPV-related oropharyngeal squamous cell carcinoma.
Authors
Bhishamjit S. Chera
Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
Bhishamjit S. Chera , Bahjat F. Qaqish , Mark C Weissler , David N. Hayes , Carol G. Shores , Alan Monroe , Roger F. Anderson , Justin Wu , Juneko E. Grilley-Olson , Jared Weiss , Trevor Hackman , Adam M Zanation , William M. Mendenhall , Robert J Amdur
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Clinical Trial Registration Number
NCT01530997
Citation
J Clin Oncol 31, 2013 (suppl; abstr TPS6097)
DOI
10.1200/jco.2013.31.15_suppl.tps6097
Abstract #
TPS6097
Poster Bd #
17E
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Two-year clinical outcomes of de-intensified chemoradiotherapy for low-risk HPV-associated oropharyngeal squamous cell carcinoma.
First Author: Bhishamjit S. Chera
Poster
2023 ASCO Annual Meeting
Pembrolizumab, radiotherapy, and chemotherapy in neoadjuvant treatment of malignant esophago-gastric diseases (PROCEED): Assessment of pathologic response and toxicity in a prospective, phase II single-arm trial.
First Author: Pooja Karukonda
Poster
2020 ASCO Virtual Scientific Program
CCTG HN.10: A phase II single-arm trial of elective volume adjusted de-escalation radiotherapy (EVADER) in patients with low-risk HPV-related oropharyngeal squamous cell carcinoma (NCT03822897).
First Author: Scott Victor Bratman
Poster
2019 ASCO Annual Meeting
Mature results of the LCCC1413 phase II trial of de-intensified chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma.
First Author: Bhishamjit S. Chera